Beam Therapeutics Inc. (BEAM)
Across 26 earnings reports since Mar 30, 2020, Beam Therapeutics Inc. (BEAM) has a clear post-earnings pattern. It moves ±6.06% on average after reporting and finishes higher 38.5% of the time. Its largest post-earnings gain was +25.89% (Feb 27, 2024) and its largest decline was -19.32% (May 06, 2025). The next earnings report is predicted for 2026-08-06 (approximate).
Earnings Price Reaction
Scroll to zoom, drag to pan — click earnings dots for details
Earnings Impact
Total Earnings
26
Avg Abs. Movement
±6.06%
Positive %
38.5%
Negative %
61.5%
Historical Earnings Statistics
| Date | Timing | Open | High | Close | Volume | Movement % | SEC Filing |
|---|---|---|---|---|---|---|---|
| May 07, 2026 | ☀ PRE | $31.64 | $32.35 | $31.44 | 84,033 | -2.75% | open_in_new |
| Feb 24, 2026 | ☀ PRE | $29.75 | $32.83 | $32.29 | 3,748,200 | +13.98% | open_in_new |
| Nov 04, 2025 | ☀ PRE | $23.12 | $23.95 | $22.74 | 3,241,100 | -6.23% | open_in_new |
| Aug 05, 2025 | ☀ PRE | $19.04 | $19.08 | $18.70 | 3,753,600 | -2.2% | open_in_new |
| May 06, 2025 | ☀ PRE | $19.30 | $19.34 | $15.99 | 5,159,200 | -19.32% | open_in_new |
| Feb 25, 2025 | ☀ PRE | $32.10 | $32.71 | $29.84 | 2,112,200 | -3.09% | open_in_new |
| Nov 05, 2024 | ☀ PRE | $21.62 | $24.79 | $23.93 | 2,301,700 | -1.77% | open_in_new |
| Aug 06, 2024 | ☀ PRE | $25.65 | $26.29 | $25.52 | 1,205,100 | -0.35% | open_in_new |
| May 07, 2024 | ☀ PRE | $22.76 | $22.93 | $22.53 | 1,287,400 | -1.1% | open_in_new |
| Feb 27, 2024 | ☀ PRE | $39.75 | $49.50 | $45.07 | 7,426,800 | +25.89% | open_in_new |
| Nov 08, 2023 | ☀ PRE | $24.71 | $24.82 | $22.90 | 1,939,400 | -8.36% | open_in_new |
| Aug 08, 2023 | ☀ PRE | $25.52 | $26.37 | $26.25 | 1,187,000 | +2.78% | open_in_new |
| May 10, 2023 | ☀ PRE | $35.00 | $36.57 | $35.85 | 1,106,600 | +3.88% | open_in_new |
| Feb 28, 2023 | ☀ PRE | $39.06 | $41.07 | $40.24 | 1,219,400 | +3.21% | open_in_new |
| Nov 07, 2022 | ☀ PRE | $39.00 | $39.52 | $37.91 | 1,873,900 | -11.43% | open_in_new |
| Aug 09, 2022 | ☀ PRE | $61.72 | $62.16 | $60.96 | 1,698,300 | -4.29% | open_in_new |
| May 09, 2022 | ☀ PRE | $34.34 | $36.71 | $33.29 | 1,917,500 | -6.7% | open_in_new |
| Feb 28, 2022 | ☀ PRE | $73.85 | $79.74 | $78.35 | 1,116,500 | +4.82% | open_in_new |
| Nov 08, 2021 | ☀ PRE | $91.58 | $99.43 | $99.06 | 773,100 | +10.64% | open_in_new |
| Aug 10, 2021 | ☀ PRE | $108.00 | $108.04 | $104.28 | 739,700 | -2.51% | open_in_new |
| May 11, 2021 | ☀ PRE | $57.39 | $71.02 | $66.20 | 2,292,500 | +3.24% | open_in_new |
| Mar 15, 2021 | ☀ PRE | $98.26 | $100.00 | $94.82 | 756,600 | -3.66% | open_in_new |
| Nov 10, 2020 | ☀ PRE | $36.19 | $37.77 | $37.68 | 416,100 | +2.03% | open_in_new |
| Aug 12, 2020 | ☀ PRE | $24.03 | $24.48 | $22.28 | 783,500 | -5.67% | open_in_new |
| May 12, 2020 | ☽ POST | $20.60 | $21.88 | $19.95 | 335,800 | +7.27% | open_in_new |
| Mar 30, 2020 | ☀ PRE | $18.00 | $18.32 | $18.00 | 106,200 | -0.28% | open_in_new |
Earnings Count
26
Total earnings in dataset
Avg Abs. Movement
±6.06%
Avg % price change on earnings
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 8-K | 20260608 | open_in_new SEC.gov |
| 4 | 20260605 | open_in_new SEC.gov |
| 4 | 20260605 | open_in_new SEC.gov |
| 4 | 20260605 | open_in_new SEC.gov |
| 4 | 20260605 | open_in_new SEC.gov |
| 4 | 20260605 | open_in_new SEC.gov |
| 4 | 20260605 | open_in_new SEC.gov |
| 10-Q | 20260507 | open_in_new SEC.gov |
| 8-K | 20260507 | open_in_new SEC.gov |
| SCHEDULE 13G | 20260429 | open_in_new SEC.gov |
Frequently asked about BEAM earnings
When does Beam Therapeutics Inc. report earnings next? expand_more
Beam Therapeutics Inc. (BEAM)'s next earnings date is approximate for 2026-08-06. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does BEAM stock move after earnings? expand_more
Over 26 reports, BEAM has moved an average of ±6.06% the session after earnings, closing higher 38.5% of the time.
What was BEAM's biggest post-earnings move? expand_more
BEAM's largest post-earnings gain on record was +25.89% on Feb 27, 2024, and its largest decline was -19.32% on May 06, 2025.
Where can I find Beam Therapeutics Inc.'s SEC filings? expand_more
All of Beam Therapeutics Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right